Tamoxifen and risk of large bowel cancer in women with breast cancer
- 1 February 1999
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 53 (3) , 271-277
- https://doi.org/10.1023/a:1006117220284
Abstract
Background: The increasingly consistent association between estrogen replacement therapy and colorectal cancer suggests that the anti-estrogen tamoxifen may also be associated with large bowel cancer...Keywords
This publication has 33 references indexed in Scilit:
- Re: Second Cancers After Adjuvant Tamoxifen Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Second Cancers After Adjuvant Tamoxifen Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Endometrial Cancer following Breast CancerEpidemiology, 1996
- Hormones and Colon CancerJNCI Journal of the National Cancer Institute, 1995
- Tamoxifen and Tumorigenicity: a Predictable ConcernJNCI Journal of the National Cancer Institute, 1995
- Estrogen Replacement Therapy and Risk of Fatal Colon Cancer in a Prospective Cohort of Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1995
- Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA)Cancer Causes & Control, 1994
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Sex steroid hormone receptors, epidermal growth factor receptor, and polyamines in human colorectal cancerDiseases of the Colon & Rectum, 1992
- Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast CancerJNCI Journal of the National Cancer Institute, 1991